These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 30911822)

  • 21. Possible role of endocannabinoids in olfactory and taste dysfunctions in Alzheimer's and Parkinson's patients and volumetric changes in the brain.
    Petekkaya E; Kuş B; Doğan S; Bayaroğulları H; Mutlu T; Murat Melek İ; Arpacı A
    J Clin Neurosci; 2022 Jun; 100():52-58. PubMed ID: 35398594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smell and Taste Impairment After Total Laryngectomy.
    Riva G; Sensini M; Corvino A; Pecorari G; Garzaro M
    Ann Otol Rhinol Laryngol; 2017 Jul; 126(7):548-554. PubMed ID: 28511547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olfactory evaluation in Mild Cognitive Impairment: correlation with neurocognitive performance and endothelial function.
    Tonacci A; Bruno RM; Ghiadoni L; Pratali L; Berardi N; Tognoni G; Cintoli S; Volpi L; Bonuccelli U; Sicari R; Taddei S; Maffei L; Picano E
    Eur J Neurosci; 2017 May; 45(10):1279-1288. PubMed ID: 28370677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory and gustatory functioning and food preferences of patients with Alzheimer's disease and mild cognitive impairment compared to controls: the NUDAD project.
    Doorduijn AS; de van der Schueren MAE; van de Rest O; de Leeuw FA; Fieldhouse JLP; Kester MI; Teunissen CE; Scheltens P; van der Flier WM; Visser M; Boesveldt S
    J Neurol; 2020 Jan; 267(1):144-152. PubMed ID: 31595376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease.
    Gjerde KV; Müller B; Skeie GO; Assmus J; Alves G; Tysnes OB
    Acta Neurol Scand; 2018 Dec; 138(6):508-514. PubMed ID: 30058142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
    Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.
    Fullard ME; Morley JF; Duda JE
    Neurosci Bull; 2017 Oct; 33(5):515-525. PubMed ID: 28831680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias.
    Ciafone J; Little B; Thomas AJ; Gallagher P
    J Int Neuropsychol Soc; 2020 Feb; 26(2):210-225. PubMed ID: 31826772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.
    Orfei MD; Assogna F; Pellicano C; Pontieri FE; Caltagirone C; Pierantozzi M; Stefani A; Spalletta G
    Parkinsonism Relat Disord; 2018 Sep; 54():62-67. PubMed ID: 29709507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired cholinergic transmission in patients with Parkinson's disease and olfactory dysfunction.
    Versace V; Langthaler PB; Sebastianelli L; Höller Y; Brigo F; Orioli A; Saltuari L; Nardone R
    J Neurol Sci; 2017 Jun; 377():55-61. PubMed ID: 28477708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.
    Skogseth RE; Bronnick K; Pereira JB; Mollenhauer B; Weintraub D; Fladby T; Aarsland D
    J Parkinsons Dis; 2015; 5(4):783-92. PubMed ID: 26599300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste.
    Niklassen AS; Draf J; Huart C; Hintschich C; Bocksberger S; Trecca EMC; Klimek L; Le Bon SD; Altundag A; Hummel T
    Laryngoscope; 2021 May; 131(5):1095-1100. PubMed ID: 33404079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemosensory function before and after multimodal treatment in chronic rhinosinusitis patients.
    Walliczek-Dworschak U; Pellegrino R; Taube F; Mueller CA; Stuck BA; Dworschak P; Güldner C; Steinbach S
    Laryngoscope; 2018 Mar; 128(3):E86-E90. PubMed ID: 28895150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of smell and taste in patients with Wegener's granulomatosis.
    Fasunla JA; Hundt W; Lutz J; Förger F; Thürmel K; Steinbach S
    Eur Arch Otorhinolaryngol; 2012 Jan; 269(1):179-86. PubMed ID: 21748655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
    Goldman JG; Weis H; Stebbins G; Bernard B; Goetz CG
    Mov Disord; 2012 Aug; 27(9):1129-36. PubMed ID: 22778009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    Wang Q; Chen B; Zhong X; Zhou H; Zhang M; Mai N; Wu Z; Huang X; Haehner A; Chen X; Auber LA; Peng Q; Hummel T; Ning Y
    J Alzheimers Dis; 2021; 79(2):585-595. PubMed ID: 33361601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.